RXRX — Recursion Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(RXRX)

Recursion Pharmaceuticals, Inc.

Live chart and latest RXRX stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

RXRX News

Recursion Pharmaceuticals Inc. (RXRX) partners with Citeline to develop AI-powered ClinTech platform

Apr 15, 2026 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors

Apr 9, 2026 TradingKey

RXRX|Recursion Pharmaceuticals Inc|Price:3.369|Chg%:0.09

Apr 10, 2026 Yahoo Finance

Is Recursion Pharmaceuticals Inc. (RXRX) The Best Overlooked Penny Stock to Invest In?

Jan 24, 2026 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know

Apr 2, 2026 Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory

Jan 20, 2026 Yahoo Finance

Jim Cramer on Recursion Pharmaceuticals: “It’s a Let Down, Big Let Down”

Mar 13, 2026 Yahoo Finance

Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy?

Dec 21, 2025 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

Mar 27, 2026 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Advances While Market Declines: Some Information for Investors

Mar 19, 2026 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know

Feb 10, 2026 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know

Feb 20, 2026 Yahoo Finance

Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Trade Below Fair Value Estimate

Feb 8, 2026 Yahoo Finance

Recursion Pharmaceuticals (RXRX) Hits Clinical Milestones as 2025 Revenue Grows to $74.7M

Feb 26, 2026 Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX) Advances AI Drug Discovery Amid Market Shifts